A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Clinical trial NCT06935370 · RECRUITING
Trial details
- NCT number
- NCT06935370
- Sponsor
- Boehringer Ingelheim
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-20
- Primary completion
- 2029-02-04
- Enrollment
- 4200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.